Multidisciplinary Perspectives on OSA Treatment with Inspire for CPAP-intolerant Patients
Panelists discuss proper patient selection, preparation for device evaluation and the procedure, and post-implant adjustments.
Panelists discuss proper patient selection, preparation for device evaluation and the procedure, and post-implant adjustments.
Health plan provider Humana Inc will provide coverage for Inspire upper airway stimulation therapy, effective August 27.
As the first FDA-cleared fully implanted neurostimulation device for obstructive sleep apnea becomes available in additional cities throughout the United States, Sleep Review provides guidance on how to screen patients for this therapy.
Three Medicare Administrative Contractors (MACs) have announced the effective release date of March 15, 2020, for their final local coverage determinations (LCD) policies covering Inspire Medical Systems Inc’s Inspire...
Read MoreTwo expert physician panelists answer audience questions about Inspire Medical Systems Inc, the makers of upper airway stimulation therapy for obstructive sleep apnea.
Read MoreData demonstrating the benefits and safety of Nyxoah SA’s Genio hypoglossal nerve...
Read MoreInspire Medical Systems, Inc, a medical technology company focused on the development and...
Read MoreThe Kettering Medical Sleep Center is offering Inspire, a device that’s implanted under the skin of the neck and chest during an outpatient procedure to treat obstructive sleep apnea. The device is controlled by a small,...
Read MoreInspire Medical Systems Inc, a medical technology company focused on the development and...
Read MoreNewly published results from 24- and 36-month data from the remed? System Pivotal Trial...
Read MoreThe international sleep medicine community gathered in New York City to discuss hypoglossal...
Read MoreInspire Medical Systems Inc, a medical technology company that makes an implantable therapy for obstructive sleep apnea (OSA) and is focused on the development and commercialization of minimally invasive solutions for patients...
Read MoreAssurance, tax, transaction and advisory services company EY announced the winners of its...
Read MoreSignifier Medical Technologies, which is developing the “Snoozeal” daytime...
Read MoreInspire Medical, Respicardia, LivaNova, and Nyxoah share the latest data on their devices.
Read MoreInspire Medical Systems Inc, a medical technology company that makes an implantable therapy for...
Read MoreThe Inspire implant has been shown to improve sleepiness and functional outcomes. Now researchers...
Read MoreNyxoah SA has received CE Mark approval for the Genio system in Europe. The Genio system is a battery-free, leadless and minimally invasive neurostimulator, capable of delivering bilateral hypoglossal nerve stimulation for...
Read More